---
figid: PMC9415106__pharmaceutics-14-01579-g004
figtitle: Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery
  of Repurposed Anthelmintics for Cancer Therapy
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9415106
filename: pharmaceutics-14-01579-g004.jpg
figlink: /pmc/articles/PMC9415106/figure/pharmaceutics-14-01579-f004/
number: F4
caption: Mode of action used by various anthelmintics to exert their anticancer effects.
  The anthelmintics work through the inhibition of tubulin polymerization to form
  microtubule, downregulation of Hedgehog signaling pathway, inhibition and downregulation
  of wnt/B-catenin pathway, and inhibition of Notch, NF-κB, mTOR, STAT3, and MEK1/2-ERK1/2
  signaling pathways; downregulation of c-Myc signaling pathway; upregulation of JNK
  signaling pathway, inhibition and downregulation of cyclin D1-CDK4 pathway; downregulation
  of pc-jun pathway; upregulation of LC3B; upregulation of DR4 and p-ERK pathways,
  and inhibition of ERK and AKT. ABZ, albendazole; IVM, ivermectin; LV, levamisole;
  MBZ, mebendazole; NIC, niclosamide; FLU, flubendazole; RAF, Rafoxanide; NTZ, nitazoxanide;
  PP, pyrvinium pamoate; EP, eprinomectin; NF-κB, nuclear factor kappa-light-chain-enhancer
  of activated B cells; mTOR, mammalian target of rapamycin; STAT3, signal transducer
  and activator of transcription 3; JNK, c-Jun N-terminal kinase; CDK4, cyclin-dependent
  kinase 4; LC3B, microtubule-associated protein 1 light chain 3B; DR4, death receptor
  4; p-ERK, phosphorylated extracellular signal-regulated protein kinase; AKT, protein
  kinase B. Reproduced with permission from ref. []. Copyright 2021 Elsevier.
papertitle: Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery
  of Repurposed Anthelmintics for Cancer Therapy.
reftext: Maedeh Koohi Moftakhari Esfahani, et al. Pharmaceutics. 2022 Aug;14(8):1579.
year: '2022'
doi: 10.3390/pharmaceutics14081579
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords: mesoporous silica nanoparticle | cancer | drug delivery | anthelmintic |
  nanomaterial | nanotechnology
automl_pathway: 0.9542558
figid_alias: PMC9415106__F4
figtype: Figure
redirect_from: /figures/PMC9415106__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9415106__pharmaceutics-14-01579-g004.html
  '@type': Dataset
  description: Mode of action used by various anthelmintics to exert their anticancer
    effects. The anthelmintics work through the inhibition of tubulin polymerization
    to form microtubule, downregulation of Hedgehog signaling pathway, inhibition
    and downregulation of wnt/B-catenin pathway, and inhibition of Notch, NF-κB, mTOR,
    STAT3, and MEK1/2-ERK1/2 signaling pathways; downregulation of c-Myc signaling
    pathway; upregulation of JNK signaling pathway, inhibition and downregulation
    of cyclin D1-CDK4 pathway; downregulation of pc-jun pathway; upregulation of LC3B;
    upregulation of DR4 and p-ERK pathways, and inhibition of ERK and AKT. ABZ, albendazole;
    IVM, ivermectin; LV, levamisole; MBZ, mebendazole; NIC, niclosamide; FLU, flubendazole;
    RAF, Rafoxanide; NTZ, nitazoxanide; PP, pyrvinium pamoate; EP, eprinomectin; NF-κB,
    nuclear factor kappa-light-chain-enhancer of activated B cells; mTOR, mammalian
    target of rapamycin; STAT3, signal transducer and activator of transcription 3;
    JNK, c-Jun N-terminal kinase; CDK4, cyclin-dependent kinase 4; LC3B, microtubule-associated
    protein 1 light chain 3B; DR4, death receptor 4; p-ERK, phosphorylated extracellular
    signal-regulated protein kinase; AKT, protein kinase B. Reproduced with permission
    from ref. []. Copyright 2021 Elsevier.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nct
  - .na.character
  - Dif
  - dl
  - Rel
  - Mtor
  - Tor
  - abz
  - Cdk4
  - Raf
  - gammaTub23C
  - betaTub56D
  - betaTub60D
  - alphaTub67C
  - alphaTub84B
  - flu
  - Jra
  - rl
  - Myc
  - bsk
  - arm
  - an
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - pan
  - Egfr
  - Erk7
  - sd
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - Akt
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - NFKB1
  - MTOR
  - STAT3
  - MAP2K1
  - MAP2K2
  - CDK4
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - TUBD1
  - TUBE1
  - TUBA1A
  - TUBA1B
  - TUBA1C
  - TUBA3C
  - TUBA3D
  - TUBA3E
  - TUBA4A
  - TUBA8
  - TUBAL3
  - TUBB
  - TUBB1
  - TUBB2A
  - TUBB2B
  - TUBB3
  - TUBB4A
  - TUBB4B
  - TUBB6
  - TUBG1
  - TUBG2
  - ZMYND10
  - JUN
  - EPHB2
  - MAPK1
  - MAPK3
  - HLA-DRB4
  - TNFRSF10A
  - MYC
  - MAPK8
  - MAPK9
  - MAPK10
  - DHH
  - IHH
  - SHH
  - MAP1LC3B
  - CTNNB1
  - AN
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - HNF4A
  - EGFR
  - YAP1
  - TEAD1
  - TEAD2
  - TEAD3
  - TEAD4
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - AKT1
  - AKT2
  - AKT3
---
